1. Home
  2. Pharma & Healthcare
  3. Global Generic Injectable Drugs Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Generic Injectable Drugs Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 109 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Generic Injectable Drugs market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Generic Injectable Drugs market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Generic Injectable Drugs in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Small Molecule
Large Molecule

Market Snapshot, By Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Teva Pharmaceutical
Sanofi
Sandoz (Novartis)
Nichi-Iko Group (Sagent)
Hospira (Pfizer Inc.)
Hikma Pharmaceuticals PLC
Grifols
Gland Pharma
Fresenius Kabi
Endo International PLC
Dr. Reddy's Laboratories Ltd
Auromedics

The study objectives of this report are:
To study and analyze the global Generic Injectable Drugs market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Generic Injectable Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Generic Injectable Drugs manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Generic Injectable Drugs market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Generic Injectable Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Generic Injectable Drugs are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Generic Injectable Drugs Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Generic Injectable Drugs Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Generic Injectable Drugs

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three

4 Market Segment: by Type
4.1 Generic Injectable Drugs Type Introduction
4.1.1 Small Molecule
4.1.2 Large Molecule
4.2 Global Generic Injectable Drugs Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Generic Injectable Drugs Type Introduction
5.1.1 Oncology
5.1.2 Anesthesia
5.1.3 Anti-Infectives
5.1.3 Parenteral Nutrition
5.1.4 Cardiovascular Diseases
5.2 Global Generic Injectable Drugs Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Generic Injectable Drugs Market by Region
6.2 North America Generic Injectable Drugs Market 2016-2021
6.3 Europe Generic Injectable Drugs Market 2016-2021
6.4 Asia Pacific Generic Injectable Drugs Market 2016-2021
6.5 South America Generic Injectable Drugs Market 2016-2021
6.6 Middle East and Africa Generic Injectable Drugs Market 2016-2021

7 North America
7.1 North America Generic Injectable Drugs Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Generic Injectable Drugs Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Generic Injectable Drugs Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Generic Injectable Drugs Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Generic Injectable Drugs Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
3.1 Teva Pharmaceutical
3.1.1 Teva Pharmaceutical Company Information
3.1.2 Teva Pharmaceutical Generic Injectable Drugs Product Portfolio, Specification and Application
3.1.3 Teva Pharmaceutical Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.1.4 Teva Pharmaceutical Key Development
3.2 Sanofi
3.2.1 Sanofi Company Information
3.2.2 Sanofi Generic Injectable Drugs Product Portfolio, Specification and Application
3.2.3 Sanofi Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.2.4 Sanofi Key Development
3.3 Sandoz (Novartis)
3.3.1 Sandoz (Novartis) Company Information
3.3.2 Sandoz (Novartis) Generic Injectable Drugs Product Portfolio, Specification and Application
3.3.3 Sandoz (Novartis) Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.3.4 Sandoz (Novartis) Key Development
3.4 Nichi-Iko Group (Sagent)
3.4.1 Nichi-Iko Group (Sagent) Company Information
3.4.2 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Portfolio, Specification and Application
3.4.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.4.4 Nichi-Iko Group (Sagent) Key Development
3.5 Hospira (Pfizer Inc.)
3.5.1 Hospira (Pfizer Inc.) Company Information
3.5.2 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Portfolio, Specification and Application
3.5.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.5.4 Hospira (Pfizer Inc.) Key Development
3.6 Hikma Pharmaceuticals PLC
3.6.1 Hikma Pharmaceuticals PLC Company Information
3.6.2 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Portfolio, Specification and Application
3.6.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.6.4 Hikma Pharmaceuticals PLC Key Development
3.7 Grifols
3.7.1 Grifols Company Information
3.7.2 Grifols Generic Injectable Drugs Product Portfolio, Specification and Application
3.7.3 Grifols Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.7.4 Hikma Pharmaceuticals PLC Key Development
3.9 Fresenius Kabi
3.9.1 Fresenius Kabi Company Information
3.9.2 Fresenius Kabi Generic Injectable Drugs Product Portfolio, Specification and Application
3.9.3 Fresenius Kabi Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.9.4 Fresenius Kabi Key Development
3.8 Gland Pharma
3.8.1 Gland Pharma Company Information
3.8.2 Gland Pharma Generic Injectable Drugs Product Portfolio, Specification and Application
3.8.3 Gland Pharma Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.8.4 Gland Pharma Key Development
3.11 Dr. Reddy's Laboratories Ltd
3.11.1 Dr. Reddy's Laboratories Ltd Company Information
3.11.2 Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Product Portfolio, Specification and Application
3.11.3 Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.11.4 Dr. Reddy's Laboratories Ltd Key Development
3.12 Auromedics
3.12.1 Auromedics Company Information
3.12.2 Auromedics Generic Injectable Drugs Product Portfolio, Specification and Application
3.12.3 Auromedics Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
3.12.4 Auromedics Key Development

13 Global Generic Injectable Drugs Market Forecast by Region by Type and by Application
13.1 Global Generic Injectable Drugs Revenue Forecast 2022-2027
13.2 Global Generic Injectable Drugs Forecast by Regions
13.3 Global Generic Injectable Drugs Forecast by Type
13.4 Global Generic Injectable Drugs Forecast by Application

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Generic Injectable Drugs Production Specifications
Table 2: Drivers in Generic Injectable Drugs Market
Table 3: Restraints Generic Injectable Drugs Market
Table 4: Opportunity in Generic Injectable Drugs Market
Table 5: Comparion of Alternative and Generic Injectable Drugs
Table 6: Generic Injectable Drugs Raw Materials Key Suppliers List
Table 7: Generic Injectable Drugs Distributors List
Table 8: Generic Injectable Drugs Major Buyers in Application One
Table 9: Generic Injectable Drugs Major Buyers in Application Two
Table 10: Generic Injectable Drugs Major Buyers in Application Three
Table 11: Global Generic Injectable Drugs Revenue (Million USD) by Type 2016-2021
Table 12: Global Generic Injectable Drugs Revenue Market Share by Type 2016-2021
Table 18: Global Generic Injectable Drugs Revenue (Million USD) by Application 2016-2021
Table 19: Global Generic Injectable Drugs Revenue Market Share by Application 2016-2021
Table 20: Global Generic Injectable Drugs Revenue (Million USD) by Region 2016-2021
Table 21: Global Generic Injectable Drugs Revenue Market Share by Region 2016-2021
Table 22: North America Generic Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 23: North America Generic Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 24: Europe Generic Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 25: Europe Generic Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Generic Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Generic Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 28: South America Generic Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 29: South America Generic Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Generic Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Generic Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 32 Teva Pharmaceutical Company Information
Table 33 Teva Pharmaceutical Generic Injectable Drugs Product Portfolio, Specification and Application
Table 34 Teva Pharmaceutical Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 35 Sanofi Company Information
Table 36 Sanofi Generic Injectable Drugs Product Portfolio, Specification and Application
Table 37 Sanofi Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 38 Sandoz (Novartis) Company Information
Table 39 Sandoz (Novartis) Generic Injectable Drugs Product Portfolio, Specification and Application
Table 40 Sandoz (Novartis) Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 41 Nichi-Iko Group (Sagent) Company Information
Table 42 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Portfolio, Specification and Application
Table 43 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 44 Hospira (Pfizer Inc.) Company Information
Table 45 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Portfolio, Specification and Application
Table 46 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 47 Hikma Pharmaceuticals PLC Company Information
Table 48 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Portfolio, Specification and Application
Table 49 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 50 Grifols Company Information
Table 51 Grifols Generic Injectable Drugs Product Portfolio, Specification and Application
Table 52 Grifols Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 53 Gland Pharma Company Information
Table 54 Gland Pharma Generic Injectable Drugs Product Portfolio, Specification and Application
Table 55 Gland Pharma Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 56 Fresenius Kabi Company Information
Table 57 Fresenius Kabi Generic Injectable Drugs Product Portfolio, Specification and Application
Table 58 Fresenius Kabi Generic Injectable Drugs Revenue and Gross Margin (2019-2021)
Table 59: Global Generic Injectable Drugs Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Generic Injectable Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Generic Injectable Drugs Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Generic Injectable Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Generic Injectable Drugs Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Generic Injectable Drugs Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Generic Injectable Drugs Picture
Figure 2: Global Generic Injectable Drugs Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Generic Injectable Drugs Industry Life Cycle
Figure 5: Product Picture of Small Molecule
Figure 6: Product Picture of Large Molecule
Figure 9: Global Generic Injectable Drugs Revenue Market Share by Type, 2020


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets